tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Soleno shares jump following competitor Acadia’s trial miss
PremiumThe FlySoleno shares jump following competitor Acadia’s trial miss
5d ago
Optimistic Outlook for ACADIA Pharmaceuticals Despite Recent Setback: Buy Rating and $32 Price Target
Premium
Ratings
Optimistic Outlook for ACADIA Pharmaceuticals Despite Recent Setback: Buy Rating and $32 Price Target
5d ago
Acadia Pharmaceuticals falls -11.2%
Premium
The Fly
Acadia Pharmaceuticals falls -11.2%
5d ago
Morgan Stanley sees ‘small impact’ on Acadia valuation from ACP-101 failure
PremiumThe FlyMorgan Stanley sees ‘small impact’ on Acadia valuation from ACP-101 failure
6d ago
Acadia Pharmaceuticals down 13% after COMPASS PWS trial misses endpoints
Premium
The Fly
Acadia Pharmaceuticals down 13% after COMPASS PWS trial misses endpoints
6d ago
Soleno jumps 11% to $63.37 after Acadia trial miss
Premium
The Fly
Soleno jumps 11% to $63.37 after Acadia trial miss
6d ago
Acadia Pharmaceuticals price target raised to $39 from $36 at UBS
PremiumThe FlyAcadia Pharmaceuticals price target raised to $39 from $36 at UBS
21d ago
Acadia Pharmaceuticals names Katcheves Chief Business and Strategy Officer
Premium
The Fly
Acadia Pharmaceuticals names Katcheves Chief Business and Strategy Officer
1M ago
Acadia Pharmaceuticals price target raised to $36 from $32 at UBS
Premium
The Fly
Acadia Pharmaceuticals price target raised to $36 from $32 at UBS
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100